• NSAIDs, Part 2: The Dawn of the Anti-Inflammatories

  • Jun 26 2024
  • Length: 47 mins
  • Podcast

NSAIDs, Part 2: The Dawn of the Anti-Inflammatories

Listen for free

View show details

  • Summary

  • In this episode, we dive into the story of aspirin and the development of ibuprofen, ending with the experiments that showed the mechanism of how aspirin actually works. Intro 0:12Review of part 1 0:28In this episode 1:04Blocking prostaglandins and willow leaves 2:26Edward Stone 3:45Johann Andreas Buchner 4:16The chemical structure of salicylic acid and creating the synthetic compound 4:44Dr. TJ MacLagan: The first trial in 1876 and treating acute rheumatism 5:16Felix Hoffmann: manipulating salicylic acid and aspirin 8:47How widespread was the use of aspirin for rheumatoid arthritis? 12:041938: problems with aspirin and endoscopies 14:581950s: long-term use of aspirin and chronic renal impairment 17:12Dr. Lawrence Craven: the use of aspirin to treat myocardial infarction 18:13Overview of what we’ve learned so far 20:48Stewart Adams: the development of ibuprofen 21:40A paper lost to time 23:29How do you test if a drug is anti-inflammatory? 25:25How do you make better aspirin? 26:551960: a trial comparing ibuprofen, baby aspirin and prednisone in patients with rheumatoid arthritis 30:03Aspirin, ibuprofen and other NSAIDs 32:49Nobel Prize winner Dr. John Vane 33:40Dr. Vane: what triggered prostaglandin production? 35:42Another guinea pig experiment 37:37Nobel Prize winner Dr. Bengt Samuelsson 39:00Interesting tidbits: early studies looking at the side effects of NSAIDs 40:011968: gastric ulcer formation and prostaglandins in rats 40:251973: renal blood flow and prostaglandins in dogs 41:531974: aspirin vs ibuprofen vs indomethacin for the heart 44:03Aspirin vs ibuprofen vs indomethacin 44:20On the next episode 46:09Thanks for listening 46:37 We’d love to hear from you! Send your comments/questions to Dr. Brown at rheuminationspodcast@healio.com. Follow us on Twitter @HRheuminations @AdamJBrownMD @HealioRheum. References: Adams SS. Inflammopharmacology. 1999;doi:10.1007/s10787-999-0002-3. https://www.aspirin-foundation.com/history/the-aspirin-story/. Buchanan WW, et al. J Rheumatol. 2002;29(6):1321-3. Cryer B, et al. Gastroenterology. 1999;doi:10.1016/s0016-5085(99)70545-7. Desborough MJR, et al. Br J Haematol. 2017;doi:10.1111/bjh.14520. Halford GM, et al. Platelets. 2012;doi:10.3109/09537104.2011.632032. Harris SC, Fosdick LS. Theoretical considerations of the mechanisms of antipyretic analgesia. NWU Bull. 1952;53: 6–9. Jasani MK, et al. Ann Rheum Dis. 1968;doi:10.1136/ard.27.5.457. Robert A, et al. Gastroenterology. 1968;55(4):481-7. Disclosures: Brown reports no relevant financial disclosures.
    Show More Show Less
Show More Show Less

What listeners say about NSAIDs, Part 2: The Dawn of the Anti-Inflammatories

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.